Crossmark

Immunohistochemical Profiling of EGFR in Triple-Negative Breast Cancer: Diagnostic Utility and Prognostic Impact

Published Online: 2025-10-13

Published Print: 2025-12

Authors

Ebrahim, Noura A. A. https://orcid.org/0009-0001-7037-680X
Amin, Nancy H.

Hussein, Mustafa A.
License Information

Text and Data Mining valid from 2025-10-13

Version of Record valid from 2025-10-13
More Information

Article History

Received: 6 June 2025

Revised: 11 September 2025

Accepted: 6 October 2025

First Online: 13 October 2025

Declarations

:

: Informed consent was obtained from all participants or their legal representatives. To ensure privacy and uphold ethical principles, all identifying details were removed. Additionally, Institutional Review Board (IRB) approval was secured from (IRB No. PA2502-501-093-197).

: Not applicable.

: The authors declare no conflicts of interest or financial relationships that could have influenced the study's findings or interpretations.

: This research adhered to the Declaration of Helsinki, ensuring the protection of patients' dignity, confidentiality, and privacy. No personal identifiers were included, and the study aimed to contribute to the advancement of medical knowledge.

Document is current